Annick Moureau

2.3k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Annick Moureau is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Annick Moureau has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Infectious Diseases and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Annick Moureau's work include Mosquito-borne diseases and control (12 papers), Malaria Research and Control (10 papers) and Viral Infections and Vectors (8 papers). Annick Moureau is often cited by papers focused on Mosquito-borne diseases and control (12 papers), Malaria Research and Control (10 papers) and Viral Infections and Vectors (8 papers). Annick Moureau collaborates with scholars based in France, United States and India. Annick Moureau's co-authors include T. Anh Wartel, Alain Bouckenooghe, Pornthep Chanthavanich, Chukiat Sirivichayakul, Kriengsak Limkittikul, Arunee Sabchareon, Mélanie Saville, Nadia Tornieporth, Krisana Pengsaa and Derek Wallace and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Annick Moureau

28 papers receiving 1.1k citations

Hit Papers

Protective efficacy of th... 2012 2026 2016 2021 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
    2012 636 citations Arunee Sabchareon, Derek Wallace et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annick Moureau France 12 875 705 172 95 72 29 1.1k
Beth-Ann Coller United States 17 668 0.8× 771 1.1× 206 1.2× 77 0.8× 50 0.7× 26 1.1k
Alienys Izquierdo Cuba 14 864 1.0× 659 0.9× 108 0.6× 73 0.8× 48 0.7× 21 973
Vianney Tricou United States 15 1.1k 1.3× 1.0k 1.5× 107 0.6× 68 0.7× 67 0.9× 44 1.4k
Louis Macareo Thailand 16 795 0.9× 621 0.9× 126 0.7× 48 0.5× 58 0.8× 44 1.0k
T. Anh Wartel South Korea 15 973 1.1× 816 1.2× 88 0.5× 97 1.0× 62 0.9× 29 1.1k
Crisanta Rocha United States 9 865 1.0× 718 1.0× 55 0.3× 36 0.4× 55 0.8× 10 935
Luís Morier Cuba 16 882 1.0× 786 1.1× 93 0.5× 47 0.5× 44 0.6× 54 1.1k
Gajanan Sapkal India 22 549 0.6× 950 1.3× 226 1.3× 30 0.3× 51 0.7× 75 1.2k
Derek Wallace United States 16 1.2k 1.4× 937 1.3× 81 0.5× 112 1.2× 75 1.0× 32 1.3k
Maïna L’Azou France 17 873 1.0× 647 0.9× 99 0.6× 34 0.4× 128 1.8× 27 1.1k

Countries citing papers authored by Annick Moureau

Since Specialization
Citations

This map shows the geographic impact of Annick Moureau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Moureau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Moureau more than expected).

Fields of papers citing papers by Annick Moureau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Moureau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Moureau. The network helps show where Annick Moureau may publish in the future.

Co-authorship network of co-authors of Annick Moureau

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Moureau. A scholar is included among the top collaborators of Annick Moureau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Moureau. Annick Moureau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moureau, Annick, et al.. (2024). Antibody-mediated protection against respiratory syncytial virus in children. European Respiratory Review. 33(174). 240106–240106. 6 indexed citations
2.
Salaun, Bruno, Jonathan De Smedt, Charlotte Vernhes, et al.. (2023). T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. Frontiers in Immunology. 14. 1260146–1260146. 5 indexed citations
3.
Mohapatra, Satyajit, Sangappa Dhaded, Sonali Kar, et al.. (2023). Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study. PLoS ONE. 18(8). e0284898–e0284898. 1 indexed citations
4.
5.
Taurel, Anne-Frieda, et al.. (2023). Age distribution of dengue cases in southern Vietnam from 2000 to 2015. PLoS neglected tropical diseases. 17(2). e0011137–e0011137. 10 indexed citations
6.
Pichon, Sylvie, Annick Moureau, Céline Petit, et al.. (2022). Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study. Vaccine. 40(33). 4780–4787. 8 indexed citations
7.
8.
Toussi, Massoud, et al.. (2022). A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update. Pharmacoepidemiology and Drug Safety. 31(7). 758–768. 1 indexed citations
9.
Palkar, Sonali, Monjori Mitra, Mandyam Dhati Ravi, et al.. (2022). Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India. Vaccine X. 10. 100137–100137. 4 indexed citations
10.
11.
12.
Guerche‐Séblain, Clotilde El, Annick Moureau, Camille Schiffler, et al.. (2019). Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial. BMC Infectious Diseases. 19(1). 308–308. 15 indexed citations
13.
Nealon, Joshua, Annick Moureau, Suresh Kumar, et al.. (2019). Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia. Vaccine. 37(39). 5891–5898. 5 indexed citations
14.
Peterson, Meagan E., You Li, André Bita, et al.. (2018). Meningococcal serogroups and surveillance: a systematic review and survey. Journal of Global Health. 9(1). 10409–10409. 61 indexed citations
15.
Nealon, Joshua, Anne-Frieda Taurel, Sutee Yoksan, et al.. (2018). Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries. The Journal of Infectious Diseases. 219(3). 375–381. 21 indexed citations
16.
Nealon, Joshua, et al.. (2017). Indonesian dengue burden estimates: review of evidence by an expert panel. Epidemiology and Infection. 145(11). 2324–2329. 26 indexed citations
17.
Nealon, Joshua, Anne-Frieda Taurel, Maria Rosario Capeding, et al.. (2016). Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial. PLoS neglected tropical diseases. 10(8). e0004918–e0004918. 37 indexed citations
18.
Plennevaux, Eric, Arunee Sabchareon, Kriengsak Limkittikul, et al.. (2016). Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction. Vaccine. 34(24). 2707–2712. 20 indexed citations
19.
Garg, Suneela, Anita Chakravarti, Ritesh Singh, et al.. (2016). Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study. International Journal of Infectious Diseases. 54. 25–30. 36 indexed citations
20.
Sabchareon, Arunee, Derek Wallace, Chukiat Sirivichayakul, et al.. (2012). Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet. 380(9853). 1559–1567. 636 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth-Ann Coller Breakdown of academic impact, for papers by Alienys Izquierdo Breakdown of academic impact, for papers by Vianney Tricou Breakdown of academic impact, for papers by Louis Macareo Breakdown of academic impact, for papers by T. Anh Wartel Breakdown of academic impact, for papers by Crisanta Rocha Breakdown of academic impact, for papers by Luís Morier Breakdown of academic impact, for papers by Gajanan Sapkal Breakdown of academic impact, for papers by Derek Wallace Breakdown of academic impact, for papers by Maïna L’Azou
Rankless by CCL
2026